The Effects of Cervical and Thoracic Manipulation Therapy Applied to Weightlifting Athletes
Launched by SELCUK UNIVERSITY · Sep 19, 2024
Trial Information
Current as of November 05, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how cervical and thoracic manipulation therapy affects the breathing and overall performance of Olympic-style weightlifters. The researchers want to find out if this type of therapy can improve the strength of respiratory muscles and enhance how well these athletes can breathe during their lifts. Previous studies have shown mixed results regarding how manipulation therapies impact breathing, especially in weightlifters, so this trial aims to provide clearer answers.
To be eligible to participate, weightlifters must have some dysfunction in their neck or upper back but should not have experienced any manipulative treatment in the last six months. Participants should not have any recent injuries, neurological or psychiatric disorders, or other medical conditions that could interfere with the treatment. If selected, participants can expect to receive targeted manipulation therapy and have their breathing functions and joint movements assessed throughout the study. This research is important as it may help improve athletic performance and provide insights into effective treatments for weightlifters.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being a weightlifter,
- • Having asymptomatic dysfunction in the cervical and thoracic spine,
- • Not having received any manipulative treatment in the last six months,
- • Individuals who do not have a condition that prevents chiropractic manipulation treatment will be included in the study.
- Exclusion Criteria:
- • Having had an injury related to the musculoskeletal system in the upper and lower extremities in the last month,
- • Having any neurological and psychiatric disorders,
- • Having cervical disc herniations,
- • Having a disorder related to the cardiac and respiratory systems,
- • Having an infectious, rheumatological, metabolic and endocrinological disorder,
- • Having dislocation, osteoporosis, ankylosing spondylitis, discopathy, rheumatoid arthritis,
- • Taking anticoagulant treatment,
- • Individuals who have recently undergone an operation involving the cervical and thoracic regions will not be included in the study.
About Selcuk University
Selçuk University is a prominent educational institution located in Turkey, recognized for its commitment to advancing medical research and clinical studies. As a clinical trial sponsor, Selçuk University leverages its extensive academic resources and expertise to conduct innovative research that aims to address significant healthcare challenges. The university fosters collaboration among researchers, healthcare professionals, and industry partners to facilitate the development of new therapies and improve patient outcomes. Through rigorous adherence to ethical standards and regulatory guidelines, Selçuk University strives to contribute to scientific knowledge and enhance the quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Konya, Selcuklu, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported